Therapeutic effects of orally administered CJLP55 for atopic dermatitis via the regulation of immune response

다국어 초록 (Multilingual Abstract)

Atopic dermatitis (AD) is an inflammatory skin condition accompanied by symptoms such as edema and hemorrhage. Kimchi is a traditional fermented Korean dish consisting of various probiotics. In this study, the therapeutic effect of <i>Lactobacillus plantarum</i> CJLP55 isolated from Kimchi was studied in AD-induced mice. Orally administered <i>Lactobacillus</i> strain, CJLP55, suppressed AD symptoms and high serum IgE levels. CJLP55 administration reduced the thickness of the epidermis, infiltration of mast cells and eosinophils into the skin lesion, enlargement of axillary lymph nodes, and increase in cell population in axillary lymph nodes. CJLP55 treatment decreased the production of type 2 cytokines, such as interleukin (IL)-4, IL-5, IL-10, IL-12, interferon (IFN)-γ, and IL-6,which were stimulated by house dust miteextracts, in the axillary lymph node cells. Orally administered CJLP55 exhibited a therapeutic effect on house dust mite-induced AD in NC⁄Nga mice after onset of the disease by altering immune cell activation. The <i>Lactobacillus</i> strain, CJLP55, isolated from Kimchi, suppressed AD. Our results suggest its possible use as a potential candidate for management of AD.